News Source: Press TV
| 2 months ago
Diabetics taking metformin (Glucophage and Fortamet) had long been reported to be at a lower risk of developing cancer. These individuals were also reported to have better outcomes in case they do get cancer. According to the study published in...
News Source: Androscoggin News
| 2 months ago
In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone, apparently by targeting cancer stem cells , report Harvard Medical School researchers in the Sept. 14 advance online...
News Source: United Press International
| 2 months ago
Drugs used to lower the risk of breast cancer in women have the side effect of increasing the likelihood of blood clots, researchers in Oregon say. The study, published in the current issue of Annals of Internal Medicine, examined the effects of...
News Source: The New York Times
| 2 months ago
Women who take drugs like raloxifene or tamoxifen can reduce their risk of developing invasive breast cancer by up to half, but they may be at greater risk for potentially serious blood clots, according to a new paper that reviews the risks and...
News Source: Reuters
| 2 months ago
Adding the common diabetes drug metformin to chemotherapy helped shrink breast cancer tumors faster in mice and keep them away longer than chemotherapy alone, raising hope for a more effective way to treat cancer, U.S. researchers said on Monday.
News Source: Androscoggin News
| 2 months ago
Adding the widely used diabetes drug metformin to conventional chemotherapy shows promise for treating and delaying recurrence of breast cancer , new research suggests. In lab tests using mice with breast cancer , researchers found that the drug...